Clinical Trial

Verifying Remote Monitoring Effect on Net Cardiovascular Outcome; RemoteVerify (RêVe)

Study acronym: ReVe
Recruiting
View on ClinicalTrials.gov →
Summary
This study investigates the impact and safety of wireless monitoring on the prognosis of heart failure patients with implanted pacemakers and defibrillators. It aims to examine the frequency of unplanned early hospital visits and the early diagnosis/intervention of disease exacerbation based on the presence or absence of wireless monitoring. Additionally, the study analyzes the influence of wireless monitoring on the patient's disease progression as well as satisfaction of the study participants.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-07-24; most recent amendment 2024-11-28.
Status change: Not Yet Recruiting → Recruiting 2023-11-20
Trial Details
NCT Number NCT05971225
Lead Sponsor Saint Vincent's Hospital, Korea
Collaborators: Biotronik SE & Co. KG
Conditions Congestive Heart Failure, Defibrillators, Cardiac Resynchronization Therapy
Enrollment 450 participants
Start Date 2023-11-11
Primary Completion 2026-10-30 (estimated)
Study Completion 2027-04-30 (estimated)
Updated on ClinicalTrials.gov 2024-12-03